Biogen (BIIB) PT Lowered to 'Street Low' $228 at Baird
Tweet Send to a Friend
Baird analyst Brian Skorney lowered the price target on Biogen (NASDAQ: BIIB) to $228.00 (from $290.00) while maintaining an Underperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
